Verizon's Q2 results beat expectations across key metrics, confirming growth momentum and effective execution of management's ...

Verizon Communications noted a surge in its AI Connect offerings during its Q2 earnings call, with the sales funnel doubling ...

Verizon's Q2 2025 results exceeded forecasts, yet concerns are being raised about profitability. Click to read more on why VZ ...

The consensus rating for AT&T is Outperform, derived from 14 analyst ratings. An average one-year price target of $30.61 ...

Gift Nifty was trading around 25,183 level, a premium of nearly 55 points from the Nifty futures’ previous close, indicating ...

Numerous factors, including Verizon’s (NYSE: VZ) valuation, yield, business traction, and analysts' sentiment, are aligning, ...

A new report from ABI Research projects that telcos could generate more than $21 billion in revenue from GPU-as-a-Service ...

EUR/USD has erased losses to retake 1.1700 in the European session on Tuesday. The pair picks up bids as the US Dollar recovery falters amid market caution, in light of the Trump-Powell feud and the ...

Silver surged Tuesday, poised to challenge last week’s 14-year high at $39.13 as precious metals capitalize on dollar ...

Major U.S. equities indexes were mixed Tuesday as investors reacted to the latest earnings reports and prepared for Big Tech ...

FTSE 100-listed (^FTSE) pharmaceuticals giant AstraZeneca (AZN.L) announced plans to invest $50bn (£37.05bn) in the US by 2030, as the threat of president Donald Trump's tariffs loom over the sector.